Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Profile: building a world-class lab from scratch.

J Cohen

    Science (New York, N.Y.)
    |July 15, 2000
    PubMed
    Summary
    This summary is machine-generated.

    Virologist John Nkengasong established a leading HIV laboratory in sub-Saharan Africa. His work clarifies properties of specific human immunodeficiency virus (HIV) strains, advancing global health.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    AIDS vaccines: is older better?

    Science (New York, N.Y.)·1992
    Same author

    AIDS vaccines. Trials set in high-risk populations.

    Science (New York, N.Y.)·1992
    Same author

    Dingell rips Healy for 'obstructionism'.

    Science (New York, N.Y.)·1992
    Same author

    Meningococcal septicaemia in a C6-deficient patient and effects of plasma transfusion on lipopolysaccharide release.

    Lancet (London, England)·1992
    Same author

    Pediatric AIDS vaccine trials set.

    Science (New York, N.Y.)·1992
    Same author

    A comparative study of imipenem versus piperacillin plus gentamicin in the initial management of febrile neutropenic patients with haematological malignancies.

    The Journal of antimicrobial chemotherapy·1992

    Area of Science:

    • Virology
    • Public Health
    • Infectious Diseases

    Background:

    • Established in 1996, Projet RETRO-CI is a U.S.-Ivoirian collaboration.
    • Funded by the U.S. Centers for Disease Control and Prevention (CDC).

    Discussion:

    • The laboratory, under Nkengasong's leadership, has become a premier facility for HIV research in sub-Saharan Africa.
    • Nkengasong's research has significantly contributed to understanding the characteristics of various HIV strains.

    Key Insights:

    • The successful development of a high-capacity virology lab demonstrates effective international scientific collaboration.
    • Nkengasong's extensive publications provide crucial data on HIV strain properties, aiding diagnostic and therapeutic advancements.

    Outlook:

    Related Experiment Videos

    • Continued research from this leading lab is expected to yield further insights into HIV evolution and epidemiology.
    • The facility serves as a model for establishing advanced infectious disease research centers in resource-limited settings.